Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wrapp

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Nature Protocols|October 6, 2021
Expression and characterization of SARS-CoV-2 spike proteinsJeffrey M Schaub, Chia-Wei Chou, Hung-Che Kuo, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structure-based Design of Prefusion-stabilized SARS-CoV-2 SpikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Science (New York, N.Y.)|July 25, 2020
Structure-based design of prefusion-stabilized SARS-CoV-2 spikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Nature Protocols|October 6, 2021
Expression and characterization of SARS-CoV-2 spike proteinsJeffrey M Schaub, Chia-Wei Chou, Hung-Che Kuo, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Structure-based Design of Prefusion-stabilized SARS-CoV-2 SpikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Science (New York, N.Y.)|July 25, 2020
Structure-based design of prefusion-stabilized SARS-CoV-2 spikesChing-Lin Hsieh, Jory A Goldsmith, Jeffrey M Schaub, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Pageof 7